Lipocine Inc. Awarded $978,000 in Grants for Qualifying Therapeutic Discovery Projects  
11/3/2010 11:30:24 AM

SALT LAKE CITY--(BUSINESS WIRE)--Lipocine Inc. ( announced today that it has been awarded four cash grants totaling approximately $978,000 under the U.S. Government’s Qualifying Therapeutic Discovery Project (“QTDP”) program. The QTDP program was part of the Patient Protection and Affordable Care Act signed into law in March 2010. The grants received by the Company related to four of the Company’s development programs in hormone replacement therapy, high-risk pregnancy support, oral treatment of progressive glioblastoma multiforme, and opioid resistant cough in advanced cancer patients.